NCT07026240Recruiting
Post-operative Monitoring of Gastric Cancer
Post-operative Monitoring of Gastric Cancer Using Circulating DNA in Blood Samples
Source: ClinicalTrials.gov · Last updated 18 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is to determine the performance of non-invasive new multi-target biomarkers in the post-operative monitoring of gastric cancer.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 258 (estimated)
- First submitted
- 4 Jun 2025
- Start date
- 18 Feb 2024
- Primary completion date
- 7 Jan 2026
- Lead sponsor
- Suzhou Huhu Health & Technology Inc.
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT07026240
What you commit to
- Study type: Observational
- Planned participants: 258
- From 18 Feb 2024 to the primary completion date, 7 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subject diagnosed previously with any kind of malignant tumor.
- Subject is receiving targeted drugs, immunosuppressants, immunomodulators, and biological therapies.
Other illness
- Subject has serious heart, liver, kidney dysfunction, or mental illness.
- Subject is known to be infected with HIV or other related diseases (considering interference from the use of immune drugs).
Other
- Researchers believe that subject is not suitable for enrollment.
- Subject can not supply sufficient sample to complete this experiment.
Who the study is looking for
- Subject age over 18.
- Subject has stomach discomfort, and seek medical attention at the Gastric Surgery Department of our center.
- Subject has or will have gastroscopy and/or pathological examination results at this center.
- Subject must be able to fully understand the informed consent form and be able to personally sign it.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fudan University Shanghai Cancer Center Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.